PE Tech Report


Like this article?

Sign up to our free newsletter

Actis invests USD32m in Sri Lankan hospital group

Actis, the pan-emerging markets private equity firm, has confirmed an investment of USD32m in the Asiri Group, a 604-bed private hospital group in Sri Lanka.

Asiri is spread across three sites in Colombo and two sites in the southern city of Matara.
Healthcare is a key focus for Actis as emerging market consumers increasingly seek high-quality medical products and services. Actis’s South Asia team has gained extensive experience in the sector with investments in the largest hospital chain in Gujarat, Sterling Add-Life; clinical research company Veeda; and India’s leading generic pharmaceutical company, Glenmark Pharmaceuticals.   

JM Trivedi, head of South Asia at Actis, says: “The rise of lifestyle diseases and increasing household income has created demand for high-quality healthcare provision which supplements government led services. Asiri is a premium private healthcare provider with an excellent reputation, carefully built-up over many years by its management team, led by Ashok Pathirage.”
Ashok Pathirage, managing director of Asiri, says: “Asiri is committed to providing its customers with compassionate medical care whilst giving them access to state of the art equipment. Patient care is our utmost priority and this investment by Actis will enable us to expand and improve our services, while building our reputation as the country’s leading hospital chain.”

Like this article? Sign up to our free newsletter